ArticlePloS one2013

Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.

Yueh-Lun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.